| PACKAGING TYPE: | 1x30 C-box |
| COMPOSITION: | Levosalbutamol Sulphate(100mcg) & Ipratropium Bromide(40mcg) |
| FORMULATION: | Capsule |
| Description: | DUORIT-L DPICAPS is a combination inhalation therapy containing Levosalbutamol Sulphate 100 mcg, a short-acting bronchodilator, and Ipratropium Bromide 40 mcg, an anticholinergic agent. It is used for the management of asthma, chronic obstructive pulmonary disease (COPD), and bronchospasm. Levosalbutamol provides rapid relief by relaxing airway muscles, while Ipratropium helps reduce bronchoconstriction and mucus secretion. This dual-action formulation ensures improved airflow, quick symptom relief, and enhanced respiratory function, delivered through DPI (Dry Powder Inhalation) caps. |
| Side Effects: | Dry mouth Tremors or nervousness Headache Palpitations Throat irritation Rare: allergic reactions |
| How to Use: | Use with a compatible DPI (Dry Powder Inhaler) device as prescribed Insert the capsule into the inhaler device Inhale deeply through the mouthpiece Do not swallow the capsule Follow proper inhalation technique for best results |
| Precaution: | Use under medical supervision Not for immediate emergency relief unless advised Avoid exceeding recommended dosage Use cautiously in patients with heart disease, glaucoma, or prostate issues Inform doctor about other medications Maintain proper inhaler hygiene |
| Product Benefits: | Provides quick relief from bronchospasm Improves airflow and breathing Dual bronchodilator action for enhanced efficacy Reduces wheezing, shortness of breath, and chest tightness Suitable for asthma and COPD management Convenient DPI capsule format f |
Frequently Asked Questions
It is used for the management of asthma, COPD, and bronchospasm.
Levosalbutamol provides quick bronchodilation, while Ipratropium offers additional airway relaxation and reduces mucus secretion.
No, it is meant for inhalation using a DPI device and should not be swallowed.















